Abstract Click to copy section linkSection link copied! Gut microbial β-glucuronidase has attracted attention as a potential therapeutic target for mitigating irinotecan (CPT-11)-induced late-onset diarrhea and intestinal injury. Here, we designed and synthesized 60 thioester derivatives bearing a 1,3,4-thiadiazole moiety and evaluated their biological activities. In vitro, 3–5B (IC50 = 0.39 μM) exhibited potent inhibitory activity against Escherichia coli β-glucuronidase (EcGUS).
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Zekai
Contact Zekai, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack